Corbus Pharmaceuticals’ $94.5 Million Shares Public Offering

Laura Testa
Tagged:

Lowenstein Sandler represented Corbus Pharmaceuticals Holdings, Inc. in the transaction.Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a precision oncology company with a diversified portfolio, announced the closing…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

…

This content is for Standard 1 Year members only.
Login Join Now